NSE filing, NSE: SUPREMEPWR. Summary written from the filing by ALFA Finder's alert engine.
Supreme Power Equipment Ltd: key numbers
- Share price
- ₹272.40
- Market cap
- ₹680.8 Cr
- Revenue (annual)
- ₹181.6 Cr
- Net profit (annual)
- ₹20.44 Cr
- P/E (TTM)
- 33.3×Sector 52.2×
- Promoter holding
- 57.16%+0.00% QoQ
- FII holding
- 0.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Supreme Power Equipment Ltd
All →Supreme Power Equipment Earnings Call Transcript: Key Takeaways
H1 FY27 income ₹135.57 Cr (+79.91%), EBITDA margin 17.42%, PAT +45.09%. Order book ₹565.80 Cr; FY27 revenue guided ₹300–350 Cr. PAT margin hedged at 9–12% amid input inflation.
Supreme Power Equipment Results Update
Supreme Power Equipment reported H1 FY27 total income of ₹135.57 Cr and net profit of ₹13.65 Cr. It also announced new orders worth ₹209.24 Cr.
- Order book
- ₹565.8 Cr
Supreme Power Equipment Investor Presentation: Key Takeaways
Supreme Power Equipment reported strong performance for H1 FY27, driven by the execution of a healthy order book and capacity expansion at the new Kannur facility. Strategy focuses on high-capacity transformers and geographic expansion.
Supreme Power Equipment Other Announcement
Supreme Power Equipment Limited confirmed no deviation in the utilization of proceeds from its preferential issue of convertible warrants for the half-year ended September 30, 2026.
Supreme Power Equipment H1 FY27 Results: Net Profit ₹13.7 Cr, Up 45.7% YoY
Supreme Power Equipment Ltd reported revenue from operations of ₹135.3 Cr (+79.9% YoY) and net profit of ₹13.7 Cr (+45.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹13.7 Cr · +45.7% YoY
Supreme Power Equipment Board Meeting Date
Supreme Power Equipment Limited will hold a board meeting on 16-Oct-2026 to consider and approve its half-yearly unaudited financial results.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.